Ireland
--:--IST
Latest
Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact Astellas Expands Its 330 Million Euro Tralee Biopharma Facility with a Second Aseptic Filling Line to Double Drug-Product Capacity Xeolas Pharmaceuticals Opens 158,000 Sq Ft State-of-the-Art Baldoyle Facility to Scale Specialty Medicine Manufacturing Priya Life Science Partners with Fleming for the 9th Annual Corporate Compliance & Transparency in Life Sciences Summit in Zurich Ireland Has the Capital and the Lessons: Digital Project Management Is How They Become Delivery Dunbar Pharma Brings First Plant-Derived Dronabinol API to UK Market Through IPS Pharma Leveraging Priya Life Science as a Data Tracker: The Ultimate Use Case & Career Guide The €100K Reality Check: Why a Six-Figure Pharma Salary in Ireland Feels Different Than in Switzerland or Germany Ireland's €93.8 Billion Non-EU Pharma Export Engine: 2025 Eurostat Trade Data and Economic Impact
Starting soon Not applicable

Evaluation of a Training Recommendation Strategy for Trail Runners.

NCT07374016 · tracked via the Priya Life Science France tracker
Phase
Not applicable
Started
2026-03
Last updated
2026-01-28

Condition(s) studied

Endurance Training

Investigational drug(s) / intervention(s)

Training recommendations GENTraining recommendations PERSOTraining recommendations PERSO-ADAPT

Training recommendations GEN: Generic training plan that will be created from a platform that is both free and popular, offering training plans for trail-running (The Decathlon Pacer application).

Training recommendations PERSO: A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the rider's level, age and gender, the time available for training and access to mountainous terrain.

Training recommendations PERSO-ADAPT: A training plan that takes into account the rider's training history, in particular the number of hours per week over the last two years, the level, age and gender of the rider, the time available for training and access to mountainous terrain. Training will also be adapted on a weekly basis according to the following feedback: state of fatigue assessed by questionnaire and heart rate variability; state of overtraining, assessed by questionnaire; degree of completion of sessions.

Study summary

Finding the optimal training, i.e. the training that enables the athlete to achieve the best performance while preserving their physical and psychological integrity, is a multi-factorial issue.

Each individual's background and training capacity are very different, hence the need for personalised training. The availability of data combined with advances in Artificial Intelligence (data modelling and analysis sciences, big data, machine learning, deep learning, etc.) offer the opportunity to refine our understanding of training and adapt recommendations according to the runner's profile for a given objective (achieving a time over a distance, completing an event, etc.). The strategy that the investigators wish to evaluate as part of this trial could make it possible to recommend an optimal training load, as well as the distribution of intensities (as a percentage of the aerobic threshold, anaerobic threshold, VVO2max, etc). The two features are (i) the personalisation will be based on training history, the level of the runner, age and gender, and the runner can focus on training, and (ii) the strategy will be adaptive, i.e. the algorithm will update the training load in real time based on contextual data about the athlete (level of fatigue via heart rate variability, feedback on recent training sessions, feelings of stress).

Eligibility

Sex
ALL
Min age
18 Years
Max age
65 Years
Healthy volunteers
Accepted
Inclusion Criteria: * Have no contraindications to trail running (Fédération Française d'Athlétisme test procedures) * Have been trail running competitively for at least 1 year * In possession of an ITRA performance index * Intends to run at least one ITRA-indexed race in the second half of the follow-up period * Own a training watch, and intend to record all training sessions of more than 10 minutes in their shared database * Have freely given their written consent. Exclusion Criteria: * Any person with chronic joint pathologies (e.g. recurrent sprains, patellar or ligament problems) or cardiac pathologies. * Any person with chronic or central neurological pathologies. * Any person deprived of their liberty or under legal protection (guardianship, curatorship, safeguard of justice, family habilitation).

Primary outcome measure(s)

  • Comparison of the ITRA performance index — Month : 10
    The main criterion for assessing the improvement in trail running performance will be the increase in the ITRA performance index of users following PERSO-ADAPT compared with the increase in the ITRA score of PERSO and GEN. The ITRA Performance Index (PI) is a tool that estimates a runner's level of performance. The performance index can be used to compare the level of different trail runners around the world and is built on a scale up to a maximum of 1000 points. The top of the scale corresponds to the theoretical best possible level.

Trial sites (1)

FacilityCityRegionStatus
Unités de Myologie et de Médecine du Sport Saint-Etienne France
Official registry record

This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.

View NCT07374016 on ClinicalTrials.gov ↗ ← All trials in France